http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2021, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 19 Feb 2020 03:01:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html for the full story. http://www.streetinsider.com/Press+Releases/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Wed, 19 Feb 2020 03:01:00 -0400 0QDU A.06822034 NEVPF NTP NTP NTP NVP http://www.streetinsider.com/Press+Releases/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html for the full story. http://www.streetinsider.com/Press+Releases/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Wed, 19 Feb 2020 03:01:00 -0400 0QDU A.06822034 NEVPF NTP NTP NTP NVP http://www.streetinsider.com/Press+Releases/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html for the full story. http://www.streetinsider.com/Press+Releases/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Wed, 19 Feb 2020 03:01:00 -0400 0QDU A.06822034 NEVPF NTP NTP NTP NVP http://www.streetinsider.com/Press+Releases/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html for the full story. http://www.streetinsider.com/Press+Releases/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Wed, 19 Feb 2020 03:01:00 -0400 0QDU A.06822034 NEVPF NTP NTP NTP NVP http://www.streetinsider.com/Press+Releases/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html for the full story. http://www.streetinsider.com/Press+Releases/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Wed, 19 Feb 2020 03:01:00 -0400 0QDU A.06822034 NEVPF NTP NTP NTP NVP http://www.streetinsider.com/Press+Releases/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html for the full story. http://www.streetinsider.com/Press+Releases/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Wed, 19 Feb 2020 03:01:00 -0400 0QDU A.06822034 NEVPF NTP NTP NTP NVP http://www.streetinsider.com/Press+Releases/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html for the full story. http://www.streetinsider.com/Press+Releases/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Wed, 19 Feb 2020 03:01:00 -0400 0QDU A.06822034 NEVPF NTP NTP NTP NVP http://www.streetinsider.com/PRNewswire/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html for the full story. http://www.streetinsider.com/PRNewswire/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Wed, 19 Feb 2020 03:01:00 -0400 0QDU A.06822034 NEVPF NTP NTP NTP NVP http://www.streetinsider.com/PRNewswire/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html for the full story. http://www.streetinsider.com/PRNewswire/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Wed, 19 Feb 2020 03:01:00 -0400 0QDU A.06822034 NEVPF NTP NTP NTP NVP http://www.streetinsider.com/PRNewswire/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html for the full story. http://www.streetinsider.com/PRNewswire/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Wed, 19 Feb 2020 03:01:00 -0400 0QDU A.06822034 NEVPF NTP NTP NTP NVP http://www.streetinsider.com/PRNewswire/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html for the full story. http://www.streetinsider.com/PRNewswire/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Wed, 19 Feb 2020 03:01:00 -0400 0QDU A.06822034 NEVPF NTP NTP NTP NVP http://www.streetinsider.com/PRNewswire/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html for the full story. http://www.streetinsider.com/PRNewswire/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Wed, 19 Feb 2020 03:01:00 -0400 0QDU A.06822034 NEVPF NTP NTP NTP NVP http://www.streetinsider.com/PRNewswire/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html for the full story. http://www.streetinsider.com/PRNewswire/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Wed, 19 Feb 2020 03:01:00 -0400 0QDU A.06822034 NEVPF NTP NTP NTP NVP http://www.streetinsider.com/PRNewswire/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html for the full story. http://www.streetinsider.com/PRNewswire/NeuroVive+Pharmaceutical+AB+Year+End+Report+January+-+December+2019/16491700.html Wed, 19 Feb 2020 03:01:00 -0400 0QDU A.06822034 NEVPF NTP NTP NTP NVP http://www.streetinsider.com/Press+Releases/NeuroVive+Completes+Recruitment+in+the+Second+Part+of+its+Ongoing+KL1333+Clinical+Phase+Iab+Study/16266450.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/NeuroVive+Completes+Recruitment+in+the+Second+Part+of+its+Ongoing+KL1333+Clinical+Phase+Iab+Study/16266450.html for the full story. http://www.streetinsider.com/Press+Releases/NeuroVive+Completes+Recruitment+in+the+Second+Part+of+its+Ongoing+KL1333+Clinical+Phase+Iab+Study/16266450.html Fri, 20 Dec 2019 09:40:00 -0400 NEVPF NVP NVP http://www.streetinsider.com/Press+Releases/NeuroVive+Completes+Recruitment+in+the+Second+Part+of+its+Ongoing+KL1333+Clinical+Phase+Iab+Study/16266450.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/NeuroVive+Completes+Recruitment+in+the+Second+Part+of+its+Ongoing+KL1333+Clinical+Phase+Iab+Study/16266450.html for the full story. http://www.streetinsider.com/Press+Releases/NeuroVive+Completes+Recruitment+in+the+Second+Part+of+its+Ongoing+KL1333+Clinical+Phase+Iab+Study/16266450.html Fri, 20 Dec 2019 09:40:00 -0400 NEVPF NVP NVP http://www.streetinsider.com/Press+Releases/NeuroVive+Completes+Recruitment+in+the+Second+Part+of+its+Ongoing+KL1333+Clinical+Phase+Iab+Study/16266450.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/NeuroVive+Completes+Recruitment+in+the+Second+Part+of+its+Ongoing+KL1333+Clinical+Phase+Iab+Study/16266450.html for the full story. http://www.streetinsider.com/Press+Releases/NeuroVive+Completes+Recruitment+in+the+Second+Part+of+its+Ongoing+KL1333+Clinical+Phase+Iab+Study/16266450.html Fri, 20 Dec 2019 09:40:00 -0400 NEVPF NVP NVP http://www.streetinsider.com/PRNewswire/NeuroVive+Completes+Recruitment+in+the+Second+Part+of+its+Ongoing+KL1333+Clinical+Phase+Iab+Study/16266450.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/NeuroVive+Completes+Recruitment+in+the+Second+Part+of+its+Ongoing+KL1333+Clinical+Phase+Iab+Study/16266450.html for the full story. http://www.streetinsider.com/PRNewswire/NeuroVive+Completes+Recruitment+in+the+Second+Part+of+its+Ongoing+KL1333+Clinical+Phase+Iab+Study/16266450.html Fri, 20 Dec 2019 09:40:00 -0400 NEVPF NVP NVP http://www.streetinsider.com/PRNewswire/NeuroVive+Completes+Recruitment+in+the+Second+Part+of+its+Ongoing+KL1333+Clinical+Phase+Iab+Study/16266450.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/NeuroVive+Completes+Recruitment+in+the+Second+Part+of+its+Ongoing+KL1333+Clinical+Phase+Iab+Study/16266450.html for the full story. http://www.streetinsider.com/PRNewswire/NeuroVive+Completes+Recruitment+in+the+Second+Part+of+its+Ongoing+KL1333+Clinical+Phase+Iab+Study/16266450.html Fri, 20 Dec 2019 09:40:00 -0400 NEVPF NVP NVP http://www.streetinsider.com/PRNewswire/NeuroVive+Completes+Recruitment+in+the+Second+Part+of+its+Ongoing+KL1333+Clinical+Phase+Iab+Study/16266450.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/NeuroVive+Completes+Recruitment+in+the+Second+Part+of+its+Ongoing+KL1333+Clinical+Phase+Iab+Study/16266450.html for the full story. http://www.streetinsider.com/PRNewswire/NeuroVive+Completes+Recruitment+in+the+Second+Part+of+its+Ongoing+KL1333+Clinical+Phase+Iab+Study/16266450.html Fri, 20 Dec 2019 09:40:00 -0400 NEVPF NVP NVP http://www.streetinsider.com/Press+Releases/NeuroVive+Announces+Settlement+in+Dispute+With+CicloMulsion+AG/16244681.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/NeuroVive+Announces+Settlement+in+Dispute+With+CicloMulsion+AG/16244681.html for the full story. http://www.streetinsider.com/Press+Releases/NeuroVive+Announces+Settlement+in+Dispute+With+CicloMulsion+AG/16244681.html Mon, 16 Dec 2019 05:19:00 -0400 0QDU NEVPF NTP NTP NTP NVP NVP http://www.streetinsider.com/Press+Releases/NeuroVive+Announces+Settlement+in+Dispute+With+CicloMulsion+AG/16244681.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/NeuroVive+Announces+Settlement+in+Dispute+With+CicloMulsion+AG/16244681.html for the full story. http://www.streetinsider.com/Press+Releases/NeuroVive+Announces+Settlement+in+Dispute+With+CicloMulsion+AG/16244681.html Mon, 16 Dec 2019 05:19:00 -0400 0QDU NEVPF NTP NTP NTP NVP NVP http://www.streetinsider.com/Press+Releases/NeuroVive+Announces+Settlement+in+Dispute+With+CicloMulsion+AG/16244681.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/NeuroVive+Announces+Settlement+in+Dispute+With+CicloMulsion+AG/16244681.html for the full story. http://www.streetinsider.com/Press+Releases/NeuroVive+Announces+Settlement+in+Dispute+With+CicloMulsion+AG/16244681.html Mon, 16 Dec 2019 05:19:00 -0400 0QDU NEVPF NTP NTP NTP NVP NVP http://www.streetinsider.com/Press+Releases/NeuroVive+Announces+Settlement+in+Dispute+With+CicloMulsion+AG/16244681.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/NeuroVive+Announces+Settlement+in+Dispute+With+CicloMulsion+AG/16244681.html for the full story. http://www.streetinsider.com/Press+Releases/NeuroVive+Announces+Settlement+in+Dispute+With+CicloMulsion+AG/16244681.html Mon, 16 Dec 2019 05:19:00 -0400 0QDU NEVPF NTP NTP NTP NVP NVP http://www.streetinsider.com/Press+Releases/NeuroVive+Announces+Settlement+in+Dispute+With+CicloMulsion+AG/16244681.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/NeuroVive+Announces+Settlement+in+Dispute+With+CicloMulsion+AG/16244681.html for the full story. http://www.streetinsider.com/Press+Releases/NeuroVive+Announces+Settlement+in+Dispute+With+CicloMulsion+AG/16244681.html Mon, 16 Dec 2019 05:19:00 -0400 0QDU NEVPF NTP NTP NTP NVP NVP